+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Suppression, subversion and escape: the role of regulatory T cells in cancer progression



Suppression, subversion and escape: the role of regulatory T cells in cancer progression



Clinical and Experimental Immunology 171(1): 36-45



Regulatory T cells (T(regs) ) are crucial in mediating immune homeostasis and promoting the establishment and maintenance of peripheral tolerance. However, in the context of cancer their role is more complex, and they are thought to contribute to the progress of many tumours. As cancer cells express both self- and tumour-associated antigens, T(regs) are key to dampening effector cell responses, and therefore represent one of the main obstacles to effective anti-tumour responses. Suppression mechanisms employed by T(regs) are thought to contribute significantly to the failure of current therapies that rely on induction or potentiation of anti-tumour responses. This review will focus on the current evidence supporting the central role of T(regs) in establishing tumour-specific tolerance and promoting cancer escape. We outline the mechanisms underlying their suppressive function and discuss the potential routes of T(regs) accumulation within the tumour, including enhanced recruitment, in-situ or local proliferation, and de-novo differentiation. In addition, we review some of the cancer treatment strategies that act, at least in part, to eliminate or interfere with the function of T(regs) . The role of T(regs) is being recognized increasingly in cancer, and controlling the function of these suppressive cells in the tumour microenvironment without compromising peripheral tolerance represents a significant challenge for cancer therapies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036547493

Download citation: RISBibTeXText

PMID: 23199321

DOI: 10.1111/j.1365-2249.2012.04657.x


Related references

Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer. Gut 61(8): 1163-1171, 2012

Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression. Cancer Research 75(21): 4483-4493, 2016

Role of Regulatory B Cells in the Progression of Cervical Cancer. Mediators of Inflammation 2019: 1-8, 2019

Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clinical Cancer Research 16(16): 4105-4112, 2010

Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation. Blood 111(4): 2112-2121, 2007

High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. European Journal of Immunology 33(2): 502-511, 2003

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines 4(3), 2016

A regulatory role of K(+)-Cl(-) cotransporter in the cell cycle progression of breast cancer MDA-MB-231 cells. Archives of Biochemistry and Biophysics 539(1): 92-98, 2013

Suppression of SIV-specific CD4+ T cells by infant but not adult macaque regulatory T cells: implications for SIV disease progression. Journal of Experimental Medicine 204(11): 2679-2692, 2007

B-type suppression: a role played by "regulatory B cells" or "regulatory plasma cells"?. European Journal of Immunology 44(5): 1251-1257, 2014

Interferon regulatory factor-1 (Irf-1) suppression and derepression during endometrial tumorigenesis and cancer progression. Cytokine 26(4): 164-168, 2004

Interferon regulatory factor-1 (IRF-1) suppression and derepression during endometrial tumorigenesis and cancer progression. Cytokine 26(4): 164-168, 2004

Different flavors of regulatory T-cell (TREG) subsets in patients with cancer and their role in tumor escape. 2007

Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter. Endocrine 44(1): 172-181, 2014

Fearful symmetry: subversion of asymmetric division in cancer development and progression. Cancer Research 75(5): 792-797, 2015